SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as its dedicated community actively champions a "permissionless brand" by developing and promoting various real-world products, including Kendu Spice on Amazon and Kendu Energy drinks. The discussion centers on the project's robust IRL presence and continuous building, positioning it as a long-term play against typical meme coin narratives. This consistent proof of work and strong community engagement is driving conviction and calls for early accumulation.

The White Whale

WHITEWHALE CRYPTO is currently a hot topic, fueled by relentless volume and substantial accumulation within the Solana ecosystem. The community is buzzing about its recent Bybit listing and a significant portion of its supply locked long-term, viewing it as a robust new standard in meme coins with strong liquidity and a rapidly growing holder base.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

Warner Bros. Discovery is at the center of an intense acquisition battle, with Paramount Skydance actively pursuing a significant all-cash bid against Netflix's mixed cash-and-stock offer. The community is divided, debating the superior value of each proposal while considering cash certainty, regulatory hurdles, and the valuation implications of a planned content spin-off.

Globalstar, Inc. engages in the provision of mobile satellite services. It offers voice and data communications services to the following markets: recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, natural resources, mining, and forestry, construction, utilities, and transportation. The company was founded in November 2003 and is headquartered in Covington, LA.

Globalstar Inc.

Globalstar is trending amid intense market speculation surrounding its valuable globally harmonized spectrum (Band n53) and advanced XCOM RAN technology. Community discussion is primarily driven by anticipation of strategic partnerships or a potential acquisition, frequently mentioning major industry players and observing ongoing FCC regulatory developments concerning spectrum usage.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending as the company navigates a landmark agreement with the U.S. government regarding drug pricing and tariff exemptions, alongside reporting robust quarterly earnings and strategic plans to spin off its Orthopaedics business. While these initiatives aim to streamline operations and enhance growth, discussions are heavily influenced by the ongoing talc litigation and significant recent jury verdicts creating an overhang.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash (BCH) is generating significant buzz due to ongoing discussions around the impending Clarity Act and its recent Quantum proof update, which has the community anticipating enhanced utility and market recognition. Investors are expressing strong bullish sentiment, noting BCH's perceived decoupling from Bitcoin and its year-to-date outperformance as key indicators for a substantial altcoin season rally. Many see BCH as an undervalued asset poised for a major breakout, with expectations of significant price appreciation.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines, Inc.

Unusual Machines, Inc. is actively trending as investors anticipate a significant boost from impending U.S. policy changes prioritizing domestic drone manufacturing, notably a ban on foreign-made drone components. The community is discussing UMAC's strategic position as a primary U.S.-based supplier of critical drone parts, expecting large government contracts and market share growth in the burgeoning "unmanned supercycle." This broader context, coupled with a Needham "Top Pick" designation, fuels conversations around the company's long-term potential amid sector-wide developments.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

Cosmos (ATOM) is trending with community discussion focused on potential price upward movement, driven by bullish chart patterns and technical analysis. Many investors are highlighting the appealing staking rewards as a primary incentive for accumulating and holding ATOM. This comes amidst ongoing conversations about the project's long-term vision as the "Internet of Blockchains" and anticipated ecosystem developments.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is a major topic of conversation ahead of an anticipated appearance at a prominent healthcare conference, with the community eagerly awaiting updates on potential strategic partnerships or a buyout. Discussions are heavily focused on the company's Matrix-M adjuvant and vaccine pipeline, especially amidst increasing global concerns about respiratory viruses. This backdrop is fueling intense investor speculation and renewed calls for significant corporate action to capitalize on its core assets.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as the community speculates intensely about an imminent major partnership or acquisition, with Novartis frequently named as a potential suitor. This heightened conversation is fueled by recent significant trading volume and anticipation surrounding the upcoming J.P. Morgan Healthcare Conference, where big pharma dealmaking is expected to accelerate for promising oncology assets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ANI Pharmaceuticals (NASDAQ:ANIP) Trading Down 6.3% - Time to Sell?

ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price Down 6.3% - Time to Sell...

ALT Stock Up 17% After Pemvidutide Gets FDA Breakthrough Tag for MASH

Altimmune shares rally 16.52% after the FDA grants Breakthrough Therapy status to pemvidutide for MASH. 

Celcuity Stock Up 677% in 6 Months: What's Behind This Huge Increase?

CELC shares surge as NDA filing and strong phase III data boost optimism around gedatolisib's potential.

ANIP Up 21% in 6 Months: Is It Worth Investing in the Stock Now?

ANI Pharmaceuticals' shares are up 21% in six months as strong 2025 results, repeated earnings beats and higher guidance highlight momentum in rare diseases.

ZBIO Tanks Despite Positive Data From Rare Autoimmune Diseases Study

Zenas BioPharma tanks nearly 52% despite positive INDIGO study data where obexelimab cut IgG4-RD flare risk by 56% and met all key endpoints.

INCY's Phase III Monjuvi Study Meets Key Goals in First-Line Lymphoma

Incyte's phase III study of Monjuvi combo for first-line DLBCL treatment met primary and key secondary goals, paving the way for a 2026 FDA filing.

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the nine brokerages that are covering the stock, MarketBeat Ratings...

Intellia Stock Declines Around 55% in 3 Months: Here's Why

NTLA shares plunge 55% in three months after the FDA placed a clinical hold on Nex-Z, suspending trials and milestone guidance following the death of a patient.

Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026

IRWD shares jump on upbeat 2026 revenue guidance amid rising Linzess demand in the United States. The company also provides a key pipeline update.

FDA Accepts SNY Filing for Expanded Use of T1D Drug in Young Children

Sanofi wins FDA priority review to expand Tzield's use to children as young as one, aiming to delay type 1 diabetes progression.

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

ANI Pharmaceuticals Inc

Yes — Rates Move Meaningfully Lower

Short-Term Dip, No Lasting Impact

No — Mostly Political Noise

Other – Comment Below

President Trump says he’s directing $200 billion into mortgage bond purchases to bring down rates and improve housing affordability. With questions around execution, authority, and real market impact, do you think this move will actually lower mortgage rates in 2026?

Will Trump’s Mortgage Bond Plan Actually Lower Rates in 2026?

ANIP
ANI Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ANIP News

ANIPANI Pharmaceuticals Inc